ArticleInternational journal of pharmaceutics2026
Topical administration of in situ gelling formulation containing myricetin-polycarboxylate nanoparticles inhibits murine genital herpes infection.
Sudipta Mallick et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.